A personalised pathway that may combine selected non-invasive neuromodulation techniques according to the clinical picture, treatment goals and relevant assessment findings.
Multi-Modal Neurostimulation is Omnia’s umbrella term for a personalised approach that can combine selected non-invasive neuromodulation techniques within one treatment programme.
Not every technique is used in every session. Components are selected according to the person’s presentation, treatment goals and relevant assessment findings, including qEEG where appropriate.
Transcranial Alternating Current Stimulation uses alternating electrical currents to influence brain activity and communication between neural networks.
Transcranial Direct Current Stimulation uses low-intensity direct current to modulate activity in targeted brain regions.
Transcranial Alternating Pink Noise Stimulation (tAPNS) uses patterned stimulation intended to influence neural activity and support brain regulation.
Transcutaneous vagus nerve stimulation applies stimulation through the skin to influence vagal and autonomic nervous-system activity.
Pulsed Electromagnetic Field Therapy (PEMF) uses pulsed electromagnetic fields as an additional physiological stimulation modality. Its role depends on the device, protocol, clinical context and evidence relevant to the proposed use.
Photobiomodulation (PBM) uses red or near-infrared light and may be considered as one component within a broader treatment plan. Its role depends on the clinical context and evidence for the proposed use.
Treatment planning may consider qEEG findings together with symptoms, clinical history and treatment goals. The exact combination should have a clear clinical rationale.
Some people may be offered one component, some a combination, and for others a different treatment pathway may be more appropriate.
Symptoms and clinical presentation
Clinical and medical history
Treatment goals and preferences
qEEG findings where clinically relevant
Response to previous treatment
Contraindications and safety factors
tDCS, PBM, tVNS, PEMF and other techniques each have their own indication-, device- and protocol-specific evidence base.
Evidence for one component does not automatically prove that a particular combination is effective or superior.
Outcomes vary. Evidence for individual techniques does not automatically establish that a particular combination will produce better or longer-lasting outcomes.
Because different techniques can be combined, the experience varies according to the modalities used. People may notice mild sensations such as tingling, tapping or warmth.
Settings can be adjusted according to comfort and individual response, and not every technique is used with every person.
Before treatment, suitability should be reviewed for the exact devices and protocols being considered. This includes relevant health history, medication, contraindications, possible effects, risks and alternatives.
Consent should explain why each component is being proposed and what is known, uncertain or still being investigated.
Progress is monitored throughout treatment. Where clinically appropriate, qEEG may be repeated to compare brain activity over time and help inform adjustments to the treatment plan.
A single modality such as neurofeedback, tDCS, TMS or biofeedback may be more appropriate than a combined programme.
Psychotherapy, psychiatric treatment, medical care or rehabilitation may be more appropriate or may continue alongside neuroscience treatment.
A combined pathway is considered only when the proposed components, clinical rationale and safety considerations are appropriate for the individual. If they are not, a different treatment approach may be recommended.
Feedback-based EEG training that may be used separately or, where clinically justified, alongside other modalities.
A dedicated page for low-intensity direct-current stimulation, including its own evidence, screening and limitations.
A light-based modality that may be considered selectively within a wider treatment plan.
Physiological feedback training for practising awareness and regulation skills.
It is called multi-modal because treatment can combine different neuromodulation techniques within the same personalised programme. The specific modalities are selected according to the person’s presentation, goals and relevant assessment findings.
Neuroplasticity is the brain’s ability to adapt and reorganise. The treatment rationale is to influence brain or nervous-system activity in ways intended to support adaptive processes, but package-level outcomes should not be guaranteed.
No. Not every modality is used with every person. Components are selected according to the individual’s brain patterns, presentation and treatment goals.
The number of sessions varies depending on the person, treatment goals and clinical response. Progress is reviewed throughout rather than using one fixed programme for everyone.
The experience depends on the techniques used. People may experience mild sensations such as tingling, tapping or warmth, and settings can be adjusted according to comfort and response.
The pathway is non-invasive and is generally well tolerated when appropriate techniques and protocols are used. Safety depends on the exact components being considered, so suitability, contraindications, possible effects and monitoring are reviewed before treatment.
Please see the Fees page for current Multi-Modal Neurostimulation pricing and practical information. The number and type of sessions can vary according to the individual plan and response over time.
A suitability consultation can clarify the clinical goals, relevant assessment findings, available alternatives and whether any combination of modalities is appropriate.